Market Overview

Mid-Day Market Update: Crude Oil Up 1.5%; Sonim Technologies Shares Plummet

Share:

Midway through trading Tuesday, the Dow traded down 0.26% to 26765.22 while the NASDAQ fell 0.67% to 8033.47. The S&P also fell, dropping 0.53% to 2,962.53.

Leading and Lagging Sectors

Energy shares climbed 1.7% on Tuesday. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 18%, and Denbury Resources Inc. (NYSE: DNR), up 12%.

In trading on Tuesday, real estate shares fell 1.7%.

Top Headline

HD Supply Holdings Inc (NASDAQ: HDS) reported in-line earnings for its second quarter, while sales missed estimates. The company issued weak forecast for the third quarter.

HD Supply Holdings reported second-quarter earnings of $1.08 per share, which met the analyst consensus estimate. The company reported quarterly sales of $1.624 billion, which missed the analyst consensus estimate of $1.63 billion

HD Supply Holdings said it expects Q3 adjusted EP of $0.96-$1.05, versus analysts’ estimates of $1.05. It projects sales of $1.62 billion-$1.67 billion, versus expectations of $1.69 billion. The company sees FY19 adjusted EPS of $3.45-$3.60 on sales of $6.1 billion-$6.2 billion.

Equities Trading UP

Francesca's Holdings Corporation (NASDAQ: FRAN) shares shot up 71% to $8.80 after the company reported Q2 EPS results up from last year.

Shares of Mallinckrodt plc (NYSE: MNK) got a boost, shooting up 61% to $3.3750 after the company agreed to sell its wholly owned subsidiary BioVectra Inc. to H.I.G. Capital, for $250 million.

Mesoblast Limited (NASDAQ: MESO) shares were also up, gaining 18% to $5.96 after the company announced it has entered into a strategic partnership with Grünentha for Europe and Latin America to develop and commercialise innovative cell therapy for the treatment of chronic back pain.

Equities Trading DOWN

Emmaus Life Sciences, Inc. (NASDAQ: EMMA) shares tumbled 39% to $2.75 after the company announced it will be delisted from the Nasdaq stock market following the hearing.

Shares of Sonim Technologies, Inc. (NASDAQ: SONM) were down 43% to $4.02. Sonim Technologies’ management has lowered its financial guidance for this fiscal year ending Dec. 31. The company says net revenues are expected to be flat or slightly below 2018 net revenues of $135.7 million reported in fiscal 2018.

Yield10 Bioscience, Inc. (NASDAQ: YTEN) was down, falling 16% to $0.6516 after the company announced a common stock offering.

Commodities

In commodity news, oil traded up 1.5% to $58.70, while gold traded down 0.6% to $1,501.80.

Silver traded down 0.1% Tuesday to $18.165, while copper fell 0.5% to $2.615.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.08%, the Spanish Ibex Index rose 0.45%, while Italy’s FTSE MIB Index fell 0.5%. Meanwhile, the German DAX rose 0.23% and the French CAC 40 slipped 0.08% while UK shares rose 0.26%.

Economics

The NFIB small business optimism index declined 1.6 points to a reading of 103.1 in August.

The number of job openings declined to 7.217 million in July, versus a revised 7.248 million in the prior month, according to the Labor Department.

The Treasury will auction 3-year notes at 1:00 p.m. ET.

Posted-In: Mid-Day Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

 

Related Articles (DNR + EMMA)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

To Celebrate Alibaba's Birthday, Jack Ma 'Returned To Where It All Started'

MedMen Says Conditions Satisfied To Close On PharmaCann Acquisition